JP Morgan Chase’s Arcellx ACLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-593,573
| Closed | -$68.1M | – | 7700 |
|
|
2026
Q1 | $68.1M | Sell |
593,573
-860,904
| -59% | -$76M | ﹤0.01% | 1193 |
|
|
2025
Q4 | $94.8M | Buy |
1,454,477
+571,974
| +65% | +$45.6M | 0.01% | 968 |
|
|
2025
Q3 | $72.5M | Sell |
882,503
-94,465
| -10% | -$6.8M | ﹤0.01% | 1168 |
|
|
2025
Q2 | $64.3M | Buy |
976,968
+293,387
| +43% | +$18.3M | ﹤0.01% | 1179 |
|
|
2025
Q1 | $44.8M | Buy |
683,581
+459,125
| +205% | +$31.1M | ﹤0.01% | 1368 |
|
|
2024
Q4 | $17.2M | Sell |
224,456
-25,667
| -10% | -$2.22M | ﹤0.01% | 2181 |
|
|
2024
Q3 | $20.9M | Sell |
250,123
-11,236
| -4% | -$748K | ﹤0.01% | 1957 |
|
|
2024
Q2 | $14.4M | Sell |
261,359
-290,391
| -53% | -$15.8M | ﹤0.01% | 2134 |
|
|
2024
Q1 | $38.4M | Sell |
551,750
-50,163
| -8% | -$3.18M | ﹤0.01% | 1444 |
|
|
2023
Q4 | $33.4M | Buy |
601,913
+38,014
| +7% | +$1.71M | ﹤0.01% | 1462 |
|
|
2023
Q3 | $20.2M | Buy |
563,899
+236,461
| +72% | +$8.15M | ﹤0.01% | 1670 |
|
|
2023
Q2 | $10.4M | Sell |
327,438
-221,759
| -40% | -$8.48M | ﹤0.01% | 2263 |
|
|
2023
Q1 | $16.9M | Sell |
549,197
-194,801
| -26% | -$5.91M | ﹤0.01% | 1809 |
|
|
2022
Q4 | $23M | Buy |
743,998
+590,980
| +386% | +$13.6M | ﹤0.01% | 1561 |
|
|
2022
Q3 | $2.87M | Buy |
153,018
+28,412
| +23% | +$544K | ﹤0.01% | 3175 |
|
|
2022
Q2 | $2.25M | Buy |
124,606
+120,340
| +2,821% | +$1.55M | ﹤0.01% | 3442 |
|
|
2022
Q1 | $60K | Buy |
+4,266
| New | +$71.3K | ﹤0.01% | 5719 |
|
Other funds holding ACLX
JP Morgan Chase's ACLX Position: Q2 2026 in Review
JP Morgan Chase sold out of Arcellx (ACLX) in Q2 2026, closing a stake of 593,573 shares — an estimated $68.1M sold.
JP Morgan Chase first reported a position in ACLX in Q1 2022 and held it in 17 quarters. The position peaked at $94.8M in Q4 2025. 2 funds tracked by Wall St. Rank hold ACLX as of Q2 2026.
- JP Morgan Chase reported no remaining Arcellx position as of Q2 2026 after selling out during the quarter.
- JP Morgan Chase sold 593,573 Arcellx shares in Q2 2026, an estimated $68.1M.
- JP Morgan Chase first reported a position in Arcellx in Q1 2022 and held it in 17 quarters.
- JP Morgan Chase's Arcellx position peaked at $94.8M in Q4 2025.
- 2 funds tracked by Wall St. Rank held Arcellx as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.